Population pharmacokinetic and pharmacodynamic analysis of rivaroxaban in Chinese patients with non-valvular atrial fibrillation
Xiaoqin Liu, Yufei Zhang, Hong-yan Ding, Ming‐Ming Yan, Zheng Jiao, Ming-kang Zhong, Chun-Lai Ma
Topics & Concepts
RivaroxabanMedicineNONMEMPharmacodynamicsAtrial fibrillationRenal functionPopulationDosingInternal medicinePharmacokineticsStroke (engine)Prothrombin timePharmacologyWarfarinEnvironmental healthMechanical engineeringEngineeringAtrial Fibrillation Management and OutcomesCardiac electrophysiology and arrhythmiasCardiac Arrhythmias and Treatments